Silverback Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Silverback Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Silverback Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Silverback Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $773k | 141k | 5.48 |
| 2023-09-30 | $905k | 239k | 3.78 |
| 2023-06-30 | $825k | 123k | 6.70 |
| 2023-03-31 | $1.3M | 197k | 6.51 |
| 2022-12-31 | $963k | 113k | 8.53 |
| 2022-06-30 | $523k | 123k | 4.25 |
| 2022-03-31 | $356k | 102k | 3.51 |
| 2021-12-31 | $521k | 78k | 6.66 |
| 2021-09-30 | $543k | 54k | 9.99 |
| 2020-12-31 | $4.1M | 88k | 46.34 |